// App-Quantinova.ai

2011 : MRD Xenotransplantation Prospectively Identifies Treatment-Selected Acute Lymphoblastic Leukemia Subpopulations with Relapse-Initiating Potential

Researchers

Presenter

  • Nina Rolf

Principal Investigators

  • Angela Tsang

  • Lorraine Liu

  • Amanda Lorentzian

  • Pascal Leclair

  • Annette Patterson

  • Philipp Lange

  • Christopher Maxwell

  • Chinten J. Lim

  • Ramon Klein Geltink

  • Suzanne M. Vercauteren

  • Gregor S. D. Reid

Medical Centers

  • Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada

  • BC Children's Hospital, Vancouver, BC, Canada

  • Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada

  • Child and Family Research Institute, University of British Columbia, Vancouver, BC, Canada

  • Department of Pathology and Laboratory Medicine, Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved